z-logo
open-access-imgOpen Access
Anabolic Drugs and Myocardial Infarction - A Clinical Case Report
Author(s) -
Rui Pontes dos Santos,
Adriana Pereira,
Henrique Jorge Guedes Neto,
Carolina Lourenço,
João Azevedo,
Paula Pinto
Publication year - 2015
Publication title -
arquivos brasileiros de cardiologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.4
H-Index - 53
eISSN - 1678-4170
pISSN - 0066-782X
DOI - 10.5935/abc.20150111
Subject(s) - medicine , myocardial infarction , anabolism , cardiology , anabolic agents , pharmacology
In most cases of myocardial infarction (MI) in young people, traditional cardiovascular risk factors continue to be of utmost importance; but at this age, other causes should also be considered, such as drug abuse.Anabolic steroids are synthetic derivatives of testosterone and are often illegally used by athletes to increase their physical performance. There is a correlation between the use of these drugs and increased cardiovascular risk1. Human growth hormone (hGH) has also been used to increase physical performance, despite the risk of cardiovascular complications2. Clenbuterol is a potent β2-agonist that also has anabolic effects. However, at present, little is known about its potential cardiovascular risk3.Despite reports of MI associated with the use of anabolic steroids, no previous studies have reported the simultaneous use of these three types of medications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom